Target

Variable Domain

1 abstract

Abstract
Phase 1 study of AM003, a novel individualized immunotherapy, in a basket of advanced solid tumors.
Org: Aummune, Institute of Oncology Angel H Roffo, Sheba Medical Center, Or-Yeuda,